NCT05618418 (BATTLE) is a clinical trial of No intervention in Alcoholic Hepatitis, sponsored by Copenhagen University Hospital, Hvidovre.

Who is sponsoring NCT05618418?

NCT05618418 is sponsored by Copenhagen University Hospital, Hvidovre.

What drugs are being tested in NCT05618418?

Interventions in NCT05618418: No intervention.

What condition does NCT05618418 study?

NCT05618418 studies Alcoholic Hepatitis.

Is NCT05618418 still recruiting?

NCT05618418 is currently status unknown. Last updated 16 November 2022.

Last reviewed 2022-11-16 · How we verify

NCT05618418: BATTLE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

BActeriophages To Treat Liver Disease Eliminating Harmful Bacteria (BATTLE)

Status unknown Last updated 16 November 2022

What this trial tests

trial testing No intervention in Alcoholic Hepatitis in 30 participants. Status unknown.

Timeline

1 July 2022

Primary endpoint
1 January 2025

1 January 2026

Quick facts

Lead sponsor	Copenhagen University Hospital, Hvidovre
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 July 2022
Primary completion	1 January 2025
Estimated completion	1 January 2026
Sites	1 location across Denmark

Drugs / interventions tested

No intervention

Conditions studied

Alcoholic Hepatitis — all drugs for Alcoholic Hepatitis →

Sponsor

Copenhagen University Hospital, Hvidovre

Who can join

18 and older, any sex, with Alcoholic Hepatitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Alcoholic hepatitis is a disease with a high mortality rate with few treatment options improving survival. Recently certain bacterial strains has been correlated to survival in patients with alcoholic hepatitis. In the BATTLE-trial the investigators will investigate if certain bacteria are correlated to decreased chance of survival in patients with alcoholic hepatitis.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Therapeutic manipulation of the microbiome in liver disease.
Parthasarathy G, Malhi H, Bajaj JS. · · 2026 · cited 4× · PMID 38922826 · DOI 10.1097/hep.0000000000000987
Low incidence of cytolysin-positive <i>E. faecalis</i> and no correlation to survival in Danish patients with alcohol-associated hepatitis: A prospective cohort study.
Cold F, Heintz JE, Ghathian KSA, Stenbøg PA, et al · · 2025 · PMID 41909880 · DOI 10.1080/29933935.2025.2549729
A Century of Bacteriophages: Insights, Applications, and Current Utilization.
Dkhili S, Ribeiro M, Slama KB. · · 2025 · PMID 41301576 · DOI 10.3390/antibiotics14111080

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Alcoholic Hepatitis

Currently open trials in the same condition.

NCT06919458 — Short Course Steroids in Alcohol Associated Hepatitis · Phase 3 · recruiting
NCT06307964 — Intra-Hepatic Microbiota in Alcoholic Hepatitis · recruiting
NCT05006430 — Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis · Phase 1, PHASE2 · recruiting
NCT05018481 — HA35 Moderate Alcoholic Hepatitis (AH) Study · EARLY_PHASE1 · recruiting
NCT02473341 — Gut-Liver Axis Modulation With IgG-Enriched Immunotherapy in Severe Alcohol-Associated Hepatitis · Phase 3 · active not recruiting

Other Copenhagen University Hospital, Hvidovre trials

Trials by the same sponsor.

NCT07321379 — Efficacy of Bicarbonate on the Risk of Assisted Delivery in Nulliparous Women With Prolonged Labour · NA · not yet recruiting
NCT07067060 — Risk of Serious Adverse Events Following Unsupervised vs Supervised Rehabilitation After Knee Arthroplasty · not yet recruiting
NCT06967324 — GRACE - Graduated Response for Advanced COPD With Enhanced Support · NA · recruiting
NCT06682260 — Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure · Phase 4 · completed
NCT06866496 — Optimized Remission in Alcohol-related Liver Cirrhosis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05618418 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Copenhagen University Hospital, Hvidovre
Last refreshed: 16 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05618418.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing